SCHEMBL17599544

SCHEMBL17599544

COC(=O)C1CCCC1c1cc(NS(=O)(=O)c2c(C)c(C)cc(C)c2C)c2ccccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ CRHBP P24387 1/20 0.45
▸ CRHR2 Q13324 1/20 0.45
▸ KEAP1 Q14145 4/20 0.42
▸ NFE2L2 Q16236 1/20 0.42
▸ SLC6A2 P23975 2/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ GAA P10253 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPT P10636 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599524 0.90 MEN1 (0.49) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL17599481 0.83 KEAP1 (0.50) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL17599564 0.81 MEN1 (0.44) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL17614128 0.75 SLC6A4 (0.52) SLC6A2SLC6A4
SCHEMBL17599414 0.73 KEAP1 (0.56) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL17599527 0.70 SLC6A3 (0.53) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL17599430 0.70 KMT2A (0.51) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL17599548 0.70 NPSR1 (0.53) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL17599450 0.69 KEAP1 (0.66) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL17599535 0.68 KDM4E (0.53) KDM4EMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP claimed
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback